[Clinical effects of naproxen and indomethacin in the treatment of progressive chronic polyarthritis (an interim report)].
D000284:Administration, Oral; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D001799:Blood Sedimentation; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011422:Propionates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D008738:Methyl Ethers; D009281:Naphthalenes; D011422:Propionates; D007213:Indomethacin
Klinischer Vergleich von Naproxen und Indomethacin in der Behandlung der progredient chronischen Polyarthritis (ein Zwischenbericht.